ASX:SKS
ASX:SKSElectrical

SKS Technologies Group (ASX:SKS) Is Up 9.2% After Doubling Profit and Lifting Dividend Tenfold – What’s Changed

SKS Technologies Group Limited recently reported significant financial growth for the fiscal year ending June 2025, including a very large 92% increase in revenue and a 111.8% rise in net profit, alongside the declaration of a fully franked dividend of 6.0 cents per share. This marks a substantial increase in shareholder returns compared to the previous year's 1.0 cent dividend and highlights the impact of robust demand in digital infrastructure and smart technology solutions. We'll look at...
ASX:RAC
ASX:RACBiotechs

Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?

Earlier this week, Race Oncology announced a scientific discovery regarding the composition of the chemotherapy drug Bisantrene and has filed three patent applications based on these findings. This move highlights the company’s continued research efforts to strengthen its intellectual property protection in the oncology treatment space. We’ll explore how Race Oncology’s patent applications on new Bisantrene discoveries may influence its investment narrative and future opportunities. Find...